Funding · Company
Eikon Therapeutics, Inc.
Hayward, CABiotech & Pharma
Eikon Therapeutics, Inc. of Hayward, CA has disclosed $1.01B across 3 Form D offerings filed with the SEC between Jan 6, 2022 and Feb 28, 2025.
$1.01B
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$351M
Form D · Feb 28, 2025 ↗
Q1 2025
· target $400M
$141M
Form D · Jun 1, 2023 ↗
Q2 2023
· target $535M
$518M
Form D · Jan 6, 2022 ↗
Q1 2022
· target $525M
Filing details
HeadquartersHayward, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001861123Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →